Nome Químico: (2S,3S)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride
Sorrisos: CC[C@@](O)(C1=CC=CC(OC)=C1)[C@@H](C)CN(C)C.Cl
Liquid–Liquid Miscibility Gaps in Drug–Water Binary Systems: Crystal Structure and Thermodynamic Properties of Prilocaine and the Temperature–Composition Phase Diagram of the Prilocaine–Water System
Ivo B. Rietveld, Marc-Antoine Perrin, Siro Toscani, Maria Barrio, Beatrice Nicolai, Josep-Lluis Tamarit, and René Ceolin
Mol. Pharmaceutics 2013, 10, 4, 1332–1339
LC Determination of Lidocaine and Prilocaine Containing Potential Risky Impurities and Application to Pharmaceuticals
Mohammad Abdul-Azim Mohammad
Chromatographia volume 70, pages563–568(2009)
Determination of prilocaine HCL in bulk drug and pharmaceutical formulation by GC-NPD method
alptug atila, yucel kadioglu
Chemical Industry and Chemical Engineering Quarterly 19(2)
Simultaneous quantification of lidocaine and prilocaine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study
Siva SankaraRao, Yadlapalli, Naresh KumarKatari, Surendra Babu, Manabolu Surya, Vijaya KumariKarra, VinuthaKommineni, Sreekantha B.Jonnalagadda
Practical Laboratory Medicine Volume 17, November 2019, e00129